319 related articles for article (PubMed ID: 36012242)
21. Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J; Thomson E; Chowdhury SR; Snow WM; Perez C; Wong TP; Fernyhough P; Albensi BC
Neuroscience; 2017 Oct; 361():81-92. PubMed ID: 28802916
[TBL] [Abstract][Full Text] [Related]
22. Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in ovariectomized mice.
Yun J; Yeo IJ; Hwang CJ; Choi DY; Im HS; Kim JY; Choi WR; Jung MH; Han SB; Hong JT
Brain Behav Immun; 2018 Oct; 73():282-293. PubMed ID: 29782911
[TBL] [Abstract][Full Text] [Related]
23. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Yan S; Xuan Z; Yang M; Wang C; Tao T; Wang Q; Cui W
Int Immunopharmacol; 2020 Apr; 81():106263. PubMed ID: 32028243
[TBL] [Abstract][Full Text] [Related]
24. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.
Uddin MS; Hasana S; Ahmad J; Hossain MF; Rahman MM; Behl T; Rauf A; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(3):402-414. PubMed ID: 33213314
[TBL] [Abstract][Full Text] [Related]
25. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
26. Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures.
Couturier J; Paccalin M; Morel M; Terro F; Milin S; Pontcharraud R; Fauconneau B; Page G
J Neuroinflammation; 2011 Jun; 8():72. PubMed ID: 21699726
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease.
Jha NK; Jha SK; Kar R; Nand P; Swati K; Goswami VK
J Neurochem; 2019 Jul; 150(2):113-137. PubMed ID: 30802950
[TBL] [Abstract][Full Text] [Related]
28. The impact of astrocytic NF-κB on healthy and Alzheimer's disease brains.
Jong Huat T; Camats-Perna J; Newcombe EA; Onraet T; Campbell D; Sucic JT; Martini A; Forner S; Mirzaei M; Poon W; LaFerla FM; Medeiros R
Sci Rep; 2024 Jun; 14(1):14305. PubMed ID: 38906984
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
31. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
32. Gedunin Inhibits Oligomeric Aβ
Tom S; Rane A; Katewa AS; Chamoli M; Matsumoto RR; Andersen JK; Chinta SJ
Mol Neurobiol; 2019 Nov; 56(11):7851-7862. PubMed ID: 31127528
[TBL] [Abstract][Full Text] [Related]
33. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
34. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
Uddin MS; Lim LW
Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
[TBL] [Abstract][Full Text] [Related]
35. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
36. The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide.
Ramberg V; Tracy LM; Samuelsson M; Nilsson LN; Iverfeldt K
J Neuroinflammation; 2011 Apr; 8():34. PubMed ID: 21492414
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.
Capiralla H; Vingtdeux V; Zhao H; Sankowski R; Al-Abed Y; Davies P; Marambaud P
J Neurochem; 2012 Feb; 120(3):461-72. PubMed ID: 22118570
[TBL] [Abstract][Full Text] [Related]
38. γ-Secretase and its modulators: Twenty years and beyond.
Xia W
Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D2 suppresses amyloid-β 25-35 induced microglial activation in BV2 cells by blocking the NF-κB inflammatory signaling pathway.
Raha S; Lee HJ; Yumnam S; Hong GE; Venkatarame Gowda Saralamma V; Ha YL; Kim JO; Kim YS; Heo JD; Lee SJ; Kim EH; Kim GS
Life Sci; 2016 Sep; 161():37-44. PubMed ID: 27477351
[TBL] [Abstract][Full Text] [Related]
40. Nf-κb: A Target for Synchronizing the Functioning Nervous Tissue Progenitors of Different Types in Alzheimer's Disease.
Zyuz'kov GN; Miroshnichenko LA; Chayikovskyi AV; Kotlovskaya LY
Curr Mol Pharmacol; 2023; 16(2):234-241. PubMed ID: 35652396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
